Media coverage about Alcentra Capital (NASDAQ:ABDC) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Alcentra Capital earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave news stories about the asset manager an impact score of 46.0158735719809 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Shares of Alcentra Capital (ABDC) remained flat at $$8.36 on Friday. The stock had a trading volume of 73,584 shares, compared to its average volume of 104,321. The company has a market cap of $119.09, a price-to-earnings ratio of -167.17 and a beta of 0.62. Alcentra Capital has a 52 week low of $7.00 and a 52 week high of $14.73.
Alcentra Capital (NASDAQ:ABDC) last issued its quarterly earnings data on Monday, November 6th. The asset manager reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.01. The company had revenue of $7.61 million for the quarter. Alcentra Capital had a positive return on equity of 11.32% and a negative net margin of 2.25%. research analysts anticipate that Alcentra Capital will post 1.29 earnings per share for the current fiscal year.
Alcentra Capital declared that its Board of Directors has approved a share buyback program on Monday, November 6th that authorizes the company to buyback $2.50 million in outstanding shares. This buyback authorization authorizes the asset manager to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.
A number of brokerages recently weighed in on ABDC. Rowe cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a report on Wednesday, November 8th. UBS Group upgraded Alcentra Capital from an “underperform” rating to a “market perform” rating in a report on Thursday, January 11th. Raymond James Financial cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a report on Wednesday, November 8th. ValuEngine upgraded Alcentra Capital from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $9.50 target price on shares of Alcentra Capital in a report on Friday, November 10th. One analyst has rated the stock with a sell rating, three have given a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $12.83.
In related news, Director Steven H. Reiff acquired 6,900 shares of Alcentra Capital stock in a transaction on Monday, November 13th. The shares were bought at an average price of $7.23 per share, for a total transaction of $49,887.00. Following the completion of the purchase, the director now directly owns 35,246 shares in the company, valued at approximately $254,828.58. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Paul J. Echausse sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $7.45, for a total value of $74,500.00. Following the transaction, the director now owns 58,946 shares in the company, valued at approximately $439,147.70. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 11,730 shares of company stock worth $83,956. 4.96% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: This news story was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3147649/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-alcentra-capital-abdc-share-price.html.
About Alcentra Capital
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.